2019-nCoV NAb Control (CLIA)
Manufactured by SHENZHEN YHLO BIOTECH CO., Ltd - www.szyhlo.com
Device identification number
1706
CE Marking
✓Yes
HSC common list
×No
HSC mutual recognition
×No
Format
Automated, Manual
Target
Antibody
Specimen
Other
Commercial Status
Commercialised
Last Update
03/16/2021 05:43
Assay Type
Immuno-Antibody
Reader Required
Yes
Subcategory
Calibrant / control sample
Method
Other
Time
30 minutes
Detection Principle
Chemiluminescence
LOD
0 AU
Calibration
not evaluated
Crossreactivity
not evaluated
Precision
evaluated
Reproducibility
evaluated
Robustness
evaluated
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements